JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer
Clinical trial NCT04951947 · RECRUITING
Trial details
- NCT number
- NCT04951947
- Sponsor
- Hunan Province Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.